ID

13597

Beschrijving

Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B; ODM derived from: https://clinicaltrials.gov/show/NCT00697840

Link

https://clinicaltrials.gov/show/NCT00697840

Trefwoorden

  1. 18-02-16 18-02-16 -
Geüploaded op

18 februari 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Hepatitis B NCT00697840

Eligibility Hepatitis B NCT00697840

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
between 18 and 40 years old.
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
written informed consent will have been obtained from the subjects.
Beschrijving

written informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
good physical condition as established by physical examination and history taking at the time of entry.
Beschrijving

good physical condition

Datatype

boolean

Alias
UMLS CUI [1]
C1142435
female participants will avoid becoming pregnant during the study period and they will have been on a contraceptive program for at least 2 months before entry
Beschrijving

pregnancy

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy or lactation.
Beschrijving

pregnancy or lactation

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
positive titres for anti hbs antibody.
Beschrijving

Hepatitis B surface antibody

Datatype

boolean

Alias
UMLS CUI [1]
C0149708
any vaccination against hepatitis b in the past.
Beschrijving

Hepatitis B vaccination

Datatype

boolean

Alias
UMLS CUI [1]
C0474232
any previous administration of mpl.
Beschrijving

mpl administration

Datatype

boolean

Alias
UMLS CUI [1]
C0066776
elevated serum liver enzymes.
Beschrijving

elevated serum liver enzymes

Datatype

boolean

Alias
UMLS CUI [1]
C1287351
history of significant and persisting hematologic, hepatic, renal, cardiac or respiratory disease.
Beschrijving

hematologic, hepatic, renal, cardiac or respiratory disease

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
axillary temperature > 37.5°c at the time of injection.
Beschrijving

axillary temperature

Datatype

boolean

Alias
UMLS CUI [1]
C1531924
any acute disease at the moment of entry.
Beschrijving

any acute disease

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
chronic alcohol consumption.
Beschrijving

chronic alcohol consumption

Datatype

boolean

Alias
UMLS CUI [1]
C0038586
any treatment with immunosuppressive or immunostimulant therapy.
Beschrijving

immunosuppressive or immunostimulant

Datatype

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0001551
any chronic drug treatment, which in the investigator's opinion, precludes inclusion into the study.
Beschrijving

drug treatment precluding inclustion into study

Datatype

boolean

Alias
UMLS CUI [1]
C0013216
UMLS CUI [2]
C1321605
history of allergic disease likely to be stimulated by any component of the vaccine.
Beschrijving

hypersensitivitiy to vaccine

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1521826
simultaneous administration of any other vaccine(s).
Beschrijving

simultaneous administration of any other vaccines

Datatype

boolean

Alias
UMLS CUI [1]
C1321605
administration of any immunoglobulin during the study period.
Beschrijving

administration of any immunoglobulin

Datatype

boolean

Alias
UMLS CUI [1]
C1321605
simultaneous participation in any other clinical trial.
Beschrijving

study participation status

Datatype

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Hepatitis B NCT00697840

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
between 18 and 40 years old.
boolean
C0001779 (UMLS CUI [1])
written informed consent
Item
written informed consent will have been obtained from the subjects.
boolean
C0021430 (UMLS CUI [1])
good physical condition
Item
good physical condition as established by physical examination and history taking at the time of entry.
boolean
C1142435 (UMLS CUI [1])
pregnancy
Item
female participants will avoid becoming pregnant during the study period and they will have been on a contraceptive program for at least 2 months before entry
boolean
C0032961 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy or lactation
Item
pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hepatitis B surface antibody
Item
positive titres for anti hbs antibody.
boolean
C0149708 (UMLS CUI [1])
Hepatitis B vaccination
Item
any vaccination against hepatitis b in the past.
boolean
C0474232 (UMLS CUI [1])
mpl administration
Item
any previous administration of mpl.
boolean
C0066776 (UMLS CUI [1])
elevated serum liver enzymes
Item
elevated serum liver enzymes.
boolean
C1287351 (UMLS CUI [1])
hematologic, hepatic, renal, cardiac or respiratory disease
Item
history of significant and persisting hematologic, hepatic, renal, cardiac or respiratory disease.
boolean
C0009488 (UMLS CUI [1])
axillary temperature
Item
axillary temperature > 37.5°c at the time of injection.
boolean
C1531924 (UMLS CUI [1])
any acute disease
Item
any acute disease at the moment of entry.
boolean
C0009488 (UMLS CUI [1])
chronic alcohol consumption
Item
chronic alcohol consumption.
boolean
C0038586 (UMLS CUI [1])
immunosuppressive or immunostimulant
Item
any treatment with immunosuppressive or immunostimulant therapy.
boolean
C0021079 (UMLS CUI [1])
C0001551 (UMLS CUI [2])
drug treatment precluding inclustion into study
Item
any chronic drug treatment, which in the investigator's opinion, precludes inclusion into the study.
boolean
C0013216 (UMLS CUI [1])
C1321605 (UMLS CUI [2])
hypersensitivitiy to vaccine
Item
history of allergic disease likely to be stimulated by any component of the vaccine.
boolean
C0020517 (UMLS CUI [1,1])
C1521826 (UMLS CUI [1,2])
simultaneous administration of any other vaccines
Item
simultaneous administration of any other vaccine(s).
boolean
C1321605 (UMLS CUI [1])
administration of any immunoglobulin
Item
administration of any immunoglobulin during the study period.
boolean
C1321605 (UMLS CUI [1])
study participation status
Item
simultaneous participation in any other clinical trial.
boolean
C2348568 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial